Aptevo Therapeutics Stock Price History
| APVO Stock | USD 0.28 0.07 20.00% |
Below is the normalized historical share price chart for Aptevo Therapeutics extending back to July 20, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aptevo Therapeutics stands at 0.28, as last reported on the 2nd of December, with the highest price reaching 0.35 and the lowest price hitting 0.28 during the day.
If you're considering investing in Aptevo Stock, it is important to understand the factors that can impact its price. Aptevo Therapeutics appears to be extremely dangerous, given 3 months investment horizon. Aptevo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0315, which signifies that the company had a 0.0315% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aptevo Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Aptevo Therapeutics' Risk Adjusted Performance of 0.0331, downside deviation of 11.9, and Mean Deviation of 7.99 to double-check if our risk estimates are consistent with your expectations.
At this time, Aptevo Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 2nd of December 2024, Stock Based Compensation is likely to grow to about 2.2 M, while Total Stockholder Equity is likely to drop about 11.6 M. . As of the 2nd of December 2024, Price To Sales Ratio is likely to drop to 4.17. In addition to that, Price Earnings Ratio is likely to drop to -0.13. Aptevo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of July 2016 | 200 Day MA 1.3536 | 50 Day MA 0.2285 | Beta 5.066 |
Aptevo |
Sharpe Ratio = 0.0315
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | APVO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.21 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Aptevo Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptevo Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.1731 | Enterprise Value Ebitda 0.3863 | Price Sales 1.6074 | Shares Float 17.5 M | Wall Street Target Price 8 |
Aptevo Therapeutics Stock Price History Chart
There are several ways to analyze Aptevo Stock price data. The simplest method is using a basic Aptevo candlestick price chart, which shows Aptevo Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 10, 2024 | 0.36 |
| Lowest Price | October 14, 2024 | 0.14 |
Aptevo Therapeutics December 2, 2024 Stock Price Synopsis
Various analyses of Aptevo Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aptevo Stock. It can be used to describe the percentage change in the price of Aptevo Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aptevo Stock.| Aptevo Therapeutics Price Daily Balance Of Power | (1.00) | |
| Aptevo Therapeutics Price Rate Of Daily Change | 0.80 | |
| Aptevo Therapeutics Price Action Indicator | (0.07) |
Aptevo Therapeutics December 2, 2024 Stock Price Analysis
Aptevo Stock Price History Data
The price series of Aptevo Therapeutics for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 0.22 with a coefficient of variation of 29.54. The prices are distributed with arithmetic mean of 0.25. The median price for the last 90 days is 0.25. The company had 1:44 stock split on 6th of March 2024. Aptevo Therapeutics issued dividends on 2020-03-27.| Open | High | Low | Close | Volume | ||
12/02/2024 | 0.34 | 0.35 | 0.28 | 0.28 | ||
| 11/29/2024 | 0.34 | 0.35 | 0.28 | 0.28 | 2,663,165 | |
| 11/27/2024 | 0.33 | 0.35 | 0.31 | 0.35 | 1,643,428 | |
| 11/26/2024 | 0.31 | 0.36 | 0.31 | 0.34 | 3,016,769 | |
| 11/25/2024 | 0.32 | 0.33 | 0.30 | 0.31 | 1,402,651 | |
| 11/22/2024 | 0.28 | 0.31 | 0.25 | 0.31 | 2,080,012 | |
| 11/21/2024 | 0.28 | 0.29 | 0.26 | 0.27 | 1,604,615 | |
| 11/20/2024 | 0.26 | 0.33 | 0.22 | 0.29 | 12,800,914 | |
| 11/19/2024 | 0.23 | 0.25 | 0.22 | 0.25 | 1,350,612 | |
| 11/18/2024 | 0.22 | 0.22 | 0.20 | 0.22 | 1,047,685 | |
| 11/15/2024 | 0.24 | 0.24 | 0.21 | 0.21 | 768,198 | |
| 11/14/2024 | 0.24 | 0.25 | 0.24 | 0.24 | 611,894 | |
| 11/13/2024 | 0.27 | 0.27 | 0.24 | 0.24 | 1,454,819 | |
| 11/12/2024 | 0.28 | 0.28 | 0.26 | 0.27 | 1,037,379 | |
| 11/11/2024 | 0.31 | 0.31 | 0.26 | 0.29 | 3,926,279 | |
| 11/08/2024 | 0.30 | 0.33 | 0.26 | 0.28 | 2,886,722 | |
| 11/07/2024 | 0.26 | 0.32 | 0.26 | 0.31 | 7,690,812 | |
| 11/06/2024 | 0.25 | 0.27 | 0.25 | 0.26 | 690,390 | |
| 11/05/2024 | 0.28 | 0.29 | 0.25 | 0.27 | 884,806 | |
| 11/04/2024 | 0.25 | 0.30 | 0.25 | 0.28 | 2,231,158 | |
| 11/01/2024 | 0.27 | 0.27 | 0.24 | 0.25 | 921,659 | |
| 10/31/2024 | 0.28 | 0.29 | 0.25 | 0.27 | 1,186,761 | |
| 10/30/2024 | 0.28 | 0.31 | 0.25 | 0.28 | 2,634,805 | |
| 10/29/2024 | 0.24 | 0.35 | 0.23 | 0.30 | 14,099,237 | |
| 10/28/2024 | 0.24 | 0.26 | 0.23 | 0.24 | 2,209,846 | |
| 10/25/2024 | 0.26 | 0.26 | 0.23 | 0.25 | 2,292,156 | |
| 10/24/2024 | 0.27 | 0.28 | 0.24 | 0.25 | 3,912,447 | |
| 10/23/2024 | 0.32 | 0.32 | 0.25 | 0.28 | 9,006,170 | |
| 10/22/2024 | 0.30 | 0.52 | 0.28 | 0.35 | 134,929,132 | |
| 10/21/2024 | 0.24 | 0.45 | 0.21 | 0.24 | 156,124,142 | |
| 10/18/2024 | 0.16 | 0.21 | 0.16 | 0.20 | 3,549,523 | |
| 10/17/2024 | 0.16 | 0.16 | 0.15 | 0.16 | 777,943 | |
| 10/16/2024 | 0.14 | 0.16 | 0.14 | 0.16 | 880,161 | |
| 10/15/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 848,300 | |
| 10/14/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 935,340 | |
| 10/11/2024 | 0.14 | 0.15 | 0.14 | 0.15 | 545,383 | |
| 10/10/2024 | 0.15 | 0.16 | 0.14 | 0.15 | 702,547 | |
| 10/09/2024 | 0.15 | 0.16 | 0.15 | 0.15 | 338,051 | |
| 10/08/2024 | 0.16 | 0.17 | 0.15 | 0.15 | 752,858 | |
| 10/07/2024 | 0.16 | 0.18 | 0.16 | 0.16 | 860,013 | |
| 10/04/2024 | 0.17 | 0.17 | 0.17 | 0.17 | 432,032 | |
| 10/03/2024 | 0.16 | 0.17 | 0.16 | 0.17 | 303,775 | |
| 10/02/2024 | 0.17 | 0.17 | 0.16 | 0.16 | 562,542 | |
| 10/01/2024 | 0.18 | 0.18 | 0.16 | 0.17 | 600,071 | |
| 09/30/2024 | 0.18 | 0.18 | 0.18 | 0.18 | 340,560 | |
| 09/27/2024 | 0.18 | 0.18 | 0.17 | 0.18 | 419,675 | |
| 09/26/2024 | 0.18 | 0.19 | 0.17 | 0.18 | 850,932 | |
| 09/25/2024 | 0.17 | 0.19 | 0.17 | 0.18 | 587,057 | |
| 09/24/2024 | 0.18 | 0.18 | 0.17 | 0.17 | 867,694 | |
| 09/23/2024 | 0.19 | 0.19 | 0.16 | 0.18 | 734,892 | |
| 09/20/2024 | 0.18 | 0.19 | 0.17 | 0.17 | 898,413 | |
| 09/19/2024 | 0.17 | 0.20 | 0.16 | 0.18 | 2,860,413 | |
| 09/18/2024 | 0.20 | 0.20 | 0.14 | 0.16 | 4,858,963 | |
| 09/17/2024 | 0.27 | 0.29 | 0.18 | 0.20 | 8,490,472 | |
| 09/16/2024 | 0.37 | 0.38 | 0.30 | 0.33 | 25,403,456 | |
| 09/13/2024 | 0.36 | 0.38 | 0.32 | 0.35 | 2,534,121 | |
| 09/12/2024 | 0.36 | 0.36 | 0.36 | 0.36 | 43,764 | |
| 09/11/2024 | 0.36 | 0.37 | 0.36 | 0.36 | 82,150 | |
| 09/10/2024 | 0.36 | 0.36 | 0.34 | 0.36 | 102,981 | |
| 09/09/2024 | 0.33 | 0.36 | 0.33 | 0.35 | 60,176 | |
| 09/06/2024 | 0.34 | 0.35 | 0.32 | 0.33 | 68,689 |
About Aptevo Therapeutics Stock history
Aptevo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aptevo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aptevo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aptevo Therapeutics stock prices may prove useful in developing a viable investing in Aptevo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 278.1 K | 292 K | |
| Net Income Applicable To Common Shares | 9.2 M | 9.7 M |
Aptevo Therapeutics Quarterly Net Working Capital |
|
Aptevo Therapeutics Stock Technical Analysis
Aptevo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Aptevo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aptevo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aptevo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aptevo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0331 | |||
| Jensen Alpha | 0.2925 | |||
| Total Risk Alpha | (1.64) | |||
| Sortino Ratio | 0.0199 | |||
| Treynor Ratio | 0.6509 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptevo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.24) | Quarterly Revenue Growth (1.00) | Return On Assets (0.73) | Return On Equity (2.51) |
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.